• Profile
Close

Bone marrow-derived mononuclear cell therapy for non-ischemic dilated cardiomyopathy: A meta-analysis

European Journal of Clinical Investigation Evidence based | Jan 27, 2018

Wen Y, et al. - As a part of this research, the effects of bone marrow-derived mononuclear cell (BMMNCs) transplantation on left ventricular ejection fraction (LVEF) were comprehensively scrutinized in patients with non-ischemic dilated cardiomyopathy (DCM). As per the results, BMMNCs transplantation exhibited a link with a moderate, yet notable, improvement in LVEF in the study cohort.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay